{
  "ticker": "LENZ",
  "name": "LENZ THERAPEUTICS, INC.",
  "quarters": [
    {
      "date": "2024-06-30T00:00:00",
      "quarter_label": "2024-06 (Q2)",
      "revenue": 0,
      "gross_profit": null,
      "operating_income": -14352000,
      "net_income": -10254000,
      "opex": 14352000,
      "cogs": null,
      "rd": 6945000,
      "sga": 7407000,
      "fcf": -15928000,
      "ocf": -15795000,
      "capex": -133000,
      "gross_margin": null,
      "op_margin": null,
      "fcf_margin": null
    },
    {
      "date": "2024-09-30T00:00:00",
      "quarter_label": "2024-09 (Q3)",
      "revenue": 0,
      "gross_profit": null,
      "operating_income": -12945000,
      "net_income": -10215000,
      "opex": 12945000,
      "cogs": null,
      "rd": 6451000,
      "sga": 6494000,
      "fcf": -10767000,
      "ocf": -10581000,
      "capex": -186000,
      "gross_margin": null,
      "op_margin": null,
      "fcf_margin": null
    },
    {
      "date": "2025-06-30T00:00:00",
      "quarter_label": "2025-06 (Q2)",
      "revenue": 5000000,
      "gross_profit": null,
      "operating_income": -16857000,
      "net_income": -14912000,
      "opex": 21857000,
      "cogs": null,
      "rd": 9061000,
      "sga": 12796000,
      "fcf": -11748000,
      "ocf": -11508000,
      "capex": -240000,
      "gross_margin": null,
      "op_margin": -3.3714,
      "fcf_margin": -2.3496,
      "incr_op_margin_yoy": -0.501
    },
    {
      "date": "2025-09-30T00:00:00",
      "quarter_label": "2025-09 (Q3)",
      "revenue": 12500000,
      "gross_profit": null,
      "operating_income": -18887000,
      "net_income": -16700000,
      "opex": 31387000,
      "cogs": null,
      "rd": 3791000,
      "sga": 27596000,
      "fcf": -9027000,
      "ocf": -8588000,
      "capex": -439000,
      "gross_margin": null,
      "op_margin": -1.51096,
      "fcf_margin": -0.72216,
      "incr_op_margin_yoy": -0.47536,
      "op_leverage_ratio": 3.4402413431269676,
      "fcf_margin_change": 1.62744
    }
  ],
  "signals": [
    {
      "quarter": "2025-09 (Q3)",
      "signal": "FCF MARGIN EXPANSION",
      "detail": "FCF margin: -235.0% -> -72.2% (+162.7%)",
      "severity": "MEDIUM"
    },
    {
      "quarter": "2025-09 (Q3)",
      "signal": "OPERATING LEVERAGE",
      "detail": "Rev growth +150.0% vs OpEx growth +43.6% (leverage: 3.4x)",
      "severity": "MEDIUM"
    }
  ],
  "data_quality": {
    "n_quarters": 4,
    "coverage": {
      "revenue": [
        4,
        4
      ],
      "gross_profit": [
        0,
        4
      ],
      "op_income": [
        4,
        4
      ],
      "fcf": [
        4,
        4
      ]
    },
    "gaps": [
      [
        "2024-09 (Q3)",
        "2025-06 (Q2)",
        273
      ]
    ],
    "warnings": [
      "gross_profit: no data",
      "gap: 2Q missing between 2024-09 (Q3) and 2025-06 (Q2)"
    ]
  },
  "market_cap": null,
  "source": "SEC EDGAR",
  "last_updated": "2026-02-02T22:18:34.805715"
}